• Company Type For Profit
  • Contact Email enquiries@mgb-biopharma.com
  • Phone Number (014) 122-8623

MGB Biopharma Limited is a biopharmaceutical company established to develop a completely new class of anti-infective medicines based upon compounds which are DNA Minor Groove Binders (MGB)

The company has an exceptionally experienced team from both pharma and biotech sectors and is dedicating its focus initially to the development of small

molecules with specific antibacterial efffects against resistant bacteria

By selecting a new class of antibacterial, the company believes the novel mode of action should prove to be very potent against bacteria as these target organisms will lack any inherent resistance, unlike that typically facing new drugs which are the result of modifications from existing classes of drugs used to treat bacterial infection

Lists Featuring This Company

Medical Device Companies (Top 10K)
9,993 Number of Organizations • $205.9B Total Funding Amount • 20,080 Number of Investors
Health Care Companies With Less Than $10M in Revenue (Top 10K)
9,906 Number of Organizations • $284.9B Total Funding Amount • 44,598 Number of Investors
Health Care Companies With Less Than $500M in Revenue (Top 10K)
9,983 Number of Organizations • $660.8B Total Funding Amount • 55,740 Number of Investors
United Kingdom Companies (Top 10K)
9,519 Number of Organizations • $455.2B Total Funding Amount • 35,337 Number of Investors

Frequently Asked Questions

Where is MGB Biopharma's headquarters? MGB Biopharma is located in Snodland, Kent, United Kingdom.Who invested in MGB Biopharma? MGB Biopharma has 7 investors including Scottish Investment Bank and TRICAPITAL.How much funding has MGB Biopharma raised to date? MGB Biopharma has raised .When was the last funding round for MGB Biopharma? MGB Biopharma closed its last funding round on Aug 30, 2019 from a Venture - Series Unknown round.Who are MGB Biopharma's competitors? Alternatives and possible competitors to MGB Biopharma may include Excision BioTherapeuticsAvisi Technologies, and Nano Precision Medical.